Key result
Transcatheter valve embolisation during TAVI carries ~40% 30-day mortality in self-expanding valve cases.
Why the study?
Predictors of transcatheter valve embolisation or migration (TVEM) during TAVI are incompletely understood, with a gap in evidence regarding CT-derived anatomical characteristics.
Cohort (n=10)
No
Answers are grounded in this paper and cite their sources.
Transcatheter valve embolisation during TAVI is a rare (0.51%) complication carrying a 40% 30-day mortality rate and frequently co-occurs with self-expanding valves, severe leaflet calcification, aorto-mitral curtain calcification, and small sinus of Valsalva dimensions.
Background Transcatheter aortic valve implantation (TAVI) has transformed the management of severe aortic stenosis, offering an effective alternative for elderly patients and those at high surgical risk who are not ideal candidates for open-heart surgery. Of late, there is an expansion into intermediate- and low-risk populations as well. Transcatheter valve embolisation or migration (TVEM) is a rare but potentially fatal complication. Predictors of TVEM are incompletely understood, and there is a gap in evidence, looking specifically at the CT-derived anatomical characteristics of TVEM. Aim This study aimed to quantify the incidence of TVEM in a high-volume tertiary centre and characterise anatomical patterns in patients experiencing TVEM during TAVI. Methods This is a retrospective, single-centre study. Patients registered as having TVEM were identified using the local database from June 2014 to June 2024. Case notes of these patients were then studied to assess the management of TVEM and outcomes. For this cohort of patients, preprocedural CTs were analysed in detail, including annulus perimeter and area, qualitative leaflet calcification grading (moderate, severe, very severe), presence of annular/aorto-mitral curtain (AMC) calcification, and minimum sinus of Valsalva (SOV) diameter. Procedural data included initial embolised valve type and the bailout strategy. Results The incidence of TVEM was 0.51% with a 30-day mortality of 40% and average length of stay in hospital of 11.5 days, compared with the uncomplicated TAVI length of stay averaging 2.1 days. There was a periprocedural complication of stroke in 10% of patients (1 patient) and no vascular access site complication. Leaflet calcification was severe or very severe in 9/10 patients, with AMC calcification present in half. The mean minimum SOV diameter was 28.7 +/- 3.5 mm (23-34 mm), and several cases demonstrated markedly constrained aortic root anatomy. All embolised valves were self-expanding devices. In 4/10 cases, a balloon-expandable THV was used as the second device, while 6/10 were treated with another self-expanding THV. Conclusion Findings suggest that TVEM is a rare complication associated with substantial short-term mortality. Severe leaflet calcification, AMC calcification, and smaller SOV dimensions were frequently observed in this cohort, and all embolised valves were self-expanding. These findings are descriptive and hypothesis-generating; without a comparator group, their association with embolisation risk cannot be established. However, these anatomical findings warrant careful preprocedural assessment, while prospective comparative studies are needed to determine their association with TVEM risk.
No takes yet. Share an insight, caveat, or question.
Dalip et al. (2026) conducted a cohort in Severe aortic stenosis complicated by transcatheter valve embolisation or migration (TVEM) during TAVI (n=10). Transcatheter valve embolisation or migration (TVEM) during TAVI managed with bail-out TAVI-ViV was evaluated on 30-day mortality. Transcatheter valve embolisation or migration occurred in 0.51% of TAVI procedures (all involving self-expanding valves) and resulted in a 40% 30-day mortality rate.
Synapse has enriched 10 related papers. Consider them for comparative context: